Medmarc is a member of ProAssurance Group, which has entered into a definitive agreement to be acquired by The Doctors Company.
Read the press release and related materials at https://proassurancegroup.com/tdc.
Created in 1979 by the healthcare technology industry, Medmarc's mission is to be the superior provider of liability insurance protection and related risk management solutions to the life sciences and medical technology industry. We support the development, testing, and delivery of medical products that save lives and improve the quality of life. Through collaboration with our parent company, ProAssurance, and our strategic alliance carriers in the U.S. and abroad, we provide innovative healthcare liability insurance solutions to the life sciences companies we serve. From ideas and prototypes to the reality of commercialization and success - We Can Meet Your Changing Needs. Contact us to discuss your life sciences insurance coverage and what coverages are needed for your business.
(703) 652-1360
Products Liability
Clinical Trials
Errors & Omissions
All Divisions
Subscribe to Medmarc's News and Resources
Upcoming Medtech and Life Sciences Events
-
RESI 2026 San Diego - Webinar Medmarc Sponsor
A discussion of products liability risks that frequently impact medical device start-ups and best practices for mitigating risks, presented by RESI San Diego sponsor Medmarc. Presented by Kate Klaus.Register for RESI 2026 San Diego - Webinar Medmarc Sponsor Read More about RESI 2026 San Diego - Webinar Medmarc Sponsor -
Animal Health Corridor Summit
Register for the 2025 Animal Health Summit. Join us in Kansas City August 31-September 1, 2026 and be a part of bringing innovation alive in animal health. Multiple days of networking, 1:1 business partnering, industry thought leaders, panels and emerging company presentations.Register for Animal Health Corridor Summit Read More about Animal Health Corridor Summit
Latest Medtech and Life Sciences Blog Posts
-
How Clinical Trial Vendors Can Quietly Expand a Sponsor’s Products Liability Exposure
As clinical trials become increasingly decentralized and operationally complex, sponsors are relying... -
Electronic Labeling Bill in Process in the U.S. Senate
Congress is considering several bills that may affect companies in the life sciences, particularly i... -
FDA Unveils Upgrades for the Agency’s Elsa AI Agent
The FDA has upgraded its Elsa artificial intelligence (AI) agent, which is now on its fourth iterati...
